Table 2.
Molnupiravir (Lagevrio): Pharmacy Assessment | |
---|---|
1 | Date of symptom onset (Must be within 5 days of filling) |
2 | High-risk condition(s) (Patients must have one or more high-risk conditions defined by the CDC) |
3 | Pregnancy Status (Must not be actively pregnant) |
4 | Pharmacy Interventions (List any pharmacist interventions made) |